Description
BSE announces the listing and admission of equity shares of Sudeep Pharma Limited on the exchange, with specific date to be notified separately.
Summary
BSE has announced that equity shares of Sudeep Pharma Limited will be listed and admitted to trading on the exchange in due course. The company has been assigned scrip code 544619, symbol SUDEEPPHRM, and ISIN number INE0QPI01025. The exact listing date and additional security details will be communicated through a separate notice.
Key Points
- Company Name: Sudeep Pharma Limited
- Scrip Code: 544619
- Trading Symbol: SUDEEPPHRM
- ISIN Number: INE0QPI01025
- Listing status: Approved for listing, exact date pending
- Notice issued by Hardik Bhuta, Assistant Vice President, BSE
Regulatory Changes
No regulatory changes are introduced by this circular. This is a standard listing notification.
Compliance Requirements
Trading members are informed of the upcoming listing and should prepare their systems to accommodate the new security once the listing date is announced. No immediate action required until the listing date notification.
Important Dates
- Notice Date: November 27, 2025
- Listing Date: To be announced through separate notice
Impact Assessment
This is a routine new listing announcement with minimal immediate market impact. The listing will add one new equity security to BSE’s trading platform. Trading members and investors interested in the pharmaceutical sector should await the separate notice containing the listing date and final security details before trading can commence.
Impact Justification
Routine new listing announcement for a single company with listing date to be announced later; limited immediate market impact